Accueil   Calls for projects   Merck - Emerging biotech grant program

Merck – Emerging biotech grant program

Key features of the call for projects

Opening date: July 20th, 2016

Date de clôture : October 1st, 2016

Dimension : Europe

Funding:

Thématique(s) médicale(s) : Auto-immunes diseases, CNS-related diseases, Genetic and rare diseases, Human health, Infectiology - Infectious diseases, Inflammatory diseases

Are you ready to unlock your molecule's potential?

 

Apply to our 2016 European Emerging Biotech Grant Program Today!

 

It is our goal to help advance lifesaving drugs to market. We understand the challenges emerging biotech companies face in the quest to push the next generation of drugs to market and we want to help you succeed!

 

That's why we're inviting you to apply to our 2016 European Emerging Biotech Grant Program. There are a total of 4 awards: First Prize is €100k, Second prize is €50k, Third and Fourth prizes are €25k each in products and services, including:

 

  • Buffers, Filters, and Resins
  • Lab-scale Hardware
  • Upstream Services
  • Consultation Services

 

To enter, please submit a completed application and tell us about your molecule before 1st October, 2016.

 

More information

 

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree